Company Name: Zafgen, Inc.    

Zafgen, Inc. is a biopharmaceutical company.  The company’s focus is on obesity and complex metabolic disorders.  The company’s lead product candidate is an obesity therapy with applications in several areas including hypothalamic injury-associated obesity (HIAO), Prader-Willi syndrome (PWS) and severe obesity.

Ticker Symbol: ZFGN (NASDAQ)

Company Website: www.zafgen.com

Social Media:

Zafgen LinkedIn

Zafgen Twitter

Headquarters: Boston, MA